HKSE:00867 has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
HKSE:00867 has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
FCF Margin % is calculated as Free Cash Flow divided by its Revenue. China Medical System Holdings's Free Cash Flow for the six months ended in Jun. 2024 was HK$443 Mil. China Medical System Holdings's Revenue for the six months ended in Jun. 2024 was HK$3,887 Mil. Therefore, China Medical System Holdings's FCF Margin % for the quarter that ended in Jun. 2024 was 11.41%.
As of today, China Medical System Holdings's current FCF Yield % is 7.05%.
The historical rank and industry rank for China Medical System Holdings's FCF Margin % or its related term are showing as below:
During the past 13 years, the highest FCF Margin % of China Medical System Holdings was 37.30%. The lowest was 0.33%. And the median was 29.43%.
The historical data trend for China Medical System Holdings's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
China Medical System Holdings Annual Data | |||||||||||||||||||||
Trend | Dec14 | Dec15 | Dec16 | Dec17 | Dec18 | Dec19 | Dec20 | Dec21 | Dec22 | Dec23 | |||||||||||
FCF Margin % | Get a 7-Day Free Trial | 36.46 | 33.84 | 27.70 | 33.10 | 27.27 |
China Medical System Holdings Semi-Annual Data | ||||||||||||||||||||
Dec14 | Jun15 | Dec15 | Jun16 | Dec16 | Jun17 | Dec17 | Jun18 | Dec18 | Jun19 | Dec19 | Jun20 | Dec20 | Jun21 | Dec21 | Jun22 | Dec22 | Jun23 | Dec23 | Jun24 | |
FCF Margin % | Get a 7-Day Free Trial | 30.89 | 35.18 | 29.85 | 23.76 | 11.41 |
For the Drug Manufacturers - Specialty & Generic subindustry, China Medical System Holdings's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Drug Manufacturers industry and Healthcare sector, China Medical System Holdings's FCF Margin % distribution charts can be found below:
* The bar in red indicates where China Medical System Holdings's FCF Margin % falls into.
FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.
China Medical System Holdings's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as
FCF Margin | = | Free Cash Flow (A: Dec. 2023 ) | / | Revenue (A: Dec. 2023 ) |
= | 2389.79 | / | 8764.762 | |
= | 27.27 % |
China Medical System Holdings's FCF Margin for the quarter that ended in Jun. 2024 is calculated as
FCF Margin | = | Free Cash Flow (Q: Jun. 2024 ) | / | Revenue (Q: Jun. 2024 ) |
= | 443.463 | / | 3887.473 | |
= | 11.41 % |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of China Medical System Holdings's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.
Treasure Sea Limited | 2101 Beneficial owner | |
Lam Kong | 2201 Interest of corporation controlled by you |
No Headlines
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.